Skip to content

Fellows Award advisory committee

Professor Marcus Munafò - Chair of Fellows Committee

Marcus Munafò is Professor of Biological Psychology at the University of Bristol. His research focuses on the neurobiological and genetic basis for tobacco and alcohol use, including smoking cessation, with two themes: the laboratory study of neurobiological pathways involved in substance use, and the large-scale longitudinal study of genetic influences on substance use and treatment response.

Recently, his research has focused on the relationship between health behaviours and both physical and mental health outcomes, using instrumental variables (e.g., Mendelian randomization) and negative control methods to elucidate the causal nature of these relationships. He is also developing programmes of work investigating the role of emotion perception biases in mental health (and the therapeutic potential of modification of these biases), and the potential of choice architecture interventions to shape lifestyle behaviours (e.g., tobacco and alcohol use) and promote public health.

Professor Felicity Callard

Dr Felicity Callard is Professor in Social Sciences for Medical Humanities at the University of Durham, as well as the Director of Hubbub (the first residency of the interdisciplinary Hub at Wellcome Collection).

Her research stretches broadly across the history and present of psychiatry; she has a particular interest in patient perspectives, interdisciplinary collaborations with neuroscientists, and the use of electronic health records.  She has worked independently as a researcher and consultant in mental health, and continues to participate in mental health policy at a European level. She has an honorary affiliation to the Institute of Psychiatry, King's College London (where she is Visiting Researcher in the Patient and Carer Participation Theme of the Biomedical Research Centre for Mental Health).

Sir Philip Campbell (ex officio)

Sir Philip Campbell is Editor-in-Chief of Nature and of the Nature Publishing Group. His areas of responsibility include the editorial content and management of Nature, and assuring the long-term quality of all Nature publications. He is based in London.

He has a BSc in aeronautical engineering, an MSc in astrophysics and a PhD and postdoctoral research in upper atmospheric physics. Following his research, he became the Physical Sciences Editor of Nature and then, in 1988, the founding editor of Physics World, the international magazine of the UK Institute of Physics. He returned to Nature to take on his current role in 1995.

He has worked with the UK government, the European Commission and the US National Institutes of Health on issues relating to science and its impacts in society. For ten years until 2012 he was a trustee of Cancer Research UK and he is a founding trustee of MQ. He is an elected Fellow of the Royal Astronomical Society and a Fellow of the Institute of Physics, has honorary degrees from several universities, and was awarded an Honorary Professorship by the Peking Union Medical College. He is a Life Member of Clare Hall, Cambridge University.

Philip is also Chair of our Board of Trustees

Professor Guy Goodwin

Professor Guy Goodwin is a Senor Research Fellow at the Department of Psychiatry, University of Oxford. His interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorders, with a focus on developing new treatments.

Professor Jeremy Hall

Professor Jeremy Hall is Director of the Neurosciences & Mental Health Research Institute at Cardiff University. His overarching interest is in the role of genetic and environmental risk factors in the development of neurodevelopmental disorders such as schizophrenia and autism. He is particularly interested in how identified penetrant genetic risk factors affect plasticity and basic learning processes in the brain, abnormalities in which underlie the key symptoms seen in a range of mental health problems.

Jeremy's current work is focussed on a range of synaptic genes and modulation of their expression and function during learning and in illness. In addition to pre-clinical work he also conduct clinical work and research in the fields of adult neurodevelopmental disorders and early psychosis.

Professor Matthew Hotopf

Matthew Hotopf is a Professor of General Hospital Psychiatry at King’s College London. His expertise is in the overlap between psychiatry and medicine; medically unexplained symptoms and their relationship with psychiatric disorder and psychological factors and the relationship between physical disease and psychiatric disorders.

Professor René Kahn

Professor René Kahn is Chair of the Department of Psychiatry and Head of the Division of Neuroscience at the University Medical Center, Utrecht, The Netherlands. His current research interests include neuroimaging in schizophrenia and the genetic dissection of complex traits in specific psychiatric disorders.

Professor Elizabeth Kuipers

Professor Elizabeth Kuipers is IOPPN Athena SWAN lead, King’s College London. She has worked in psychosis for most of her career. She was drawn to it as in the 1970’s, there were almost no psychological therapies available, a lot of pessimism about outcomes, and little psychological understanding of its distressing symptoms and what was maintaining them.

With colleagues, she was initially interested in developing and evaluating interventions to help the whole family cope with the problems and subsequently in developing  and evaluating individual cognitive behavioural interventions.

Professor Richard Morris (ex officio)

Richard Morris is Professor of Neuroscience at the University of Edinburgh and an Adjunct Professor of the Norwegian Technical University in Trondheim (NTNU). He graduated in Natural Sciences at the University of Cambridge in 1969 and completed a D.Phil at the University of Sussex.

He had time out of academic life in the 1970s helping to build the Human Biology Exhibition at the Natural History Museum in London and then working for the Science and Features Department of BBC Television (on “Tomorrow’s World”). After this, he assumed a Lectureship in St Andrews before moving later to Edinburgh. During his career, he has been seconded to other activities, including the Foresight Office of the Department of Trade and Industry and, more recently, as Head of Neuroscience at the Wellcome Trust from 2007 to 2010. He has also been active in public awareness of science activities throughout his career, notably with the Dana Foundation. He is a member of the Council of the European Dana Alliance for the Brain.

His principal research interest is the neurobiology of learning and memory. In 1986, he made the key observation that activation of NMDA receptors in the hippocampus is critical for memory encoding. Other contributions include the development of the open-field ‘watermaze’, now used worldwide, joint development (with Julie Frey) of the ‘synaptic tagging and capture’ hypothesis and, more recently, new paradigms to study paired-associate recall in animals and gene-activation associated with the encoding and assimilation of new information into mental schemas.

He was elected to Fellowship of the Royal Society in 1997. He is also a Fellow of a number of other institutions, including the American Academy of Arts and Sciences. He has won several awards, notably the Zotterman Medal of the Swedish Physiological Society in Stockholm (1999), the Feldberg Prize (2006) and the Fondation Ipsen Neuronal Plasticity Prize (2013), and has served as President of the Federation of European Neuroscience Societies (2006-2008). He was awarded a CBE in 2007.

Richard is also a trustee at MQ. 

Professor Carmen Sandi

Professor Carmen Sandi is Director of the Brain Mind Institute, where she heads the Laboratory of Behavioral Genetics, Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland.

Her lab investigates the impact and mechanisms whereby stress affects brain function and cognition, with a focus on social behaviours, cognition and psychiatric disorders - such as anxiety, depression and pathological aggression. They are exploring the mechanisms that lead from early life exposure to traumatic stress to the development of violent behaviours, including changes in neurodevelopmental trajectories, synaptic cell adhesion molecules and epigenetic mechanisms. Another project in the lab addresses the impact of stress and anxiety trait in the development of social hierarchies, with a focus on the mesolimbic system and energy metabolism. These animal studies are currently being complemented by approaches in humans in the emerging field of behavioural and neural economics.

Subscribe to our newsletter. Get the latest news on mental health.

© MQ: Transforming mental health 2016 | Registered charity in England / Wales: 1139916 & Scotland: SC046075 | Company number: 7406055